RHHBF
Price
$333.36
Change
-$6.64 (-1.95%)
Updated
Jun 30 closing price
Capitalization
250.69B
RHHBY
Price
$40.44
Change
-$0.71 (-1.73%)
Updated
Jul 3 closing price
Capitalization
250.69B
17 days until earnings call
Interact to see
Advertisement

RHHBF vs RHHBY

Header iconRHHBF vs RHHBY Comparison
Open Charts RHHBF vs RHHBYBanner chart's image
Roche Holding
Price$333.36
Change-$6.64 (-1.95%)
Volume$15
Capitalization250.69B
Roche Holding
Price$40.44
Change-$0.71 (-1.73%)
Volume$624.51K
Capitalization250.69B
RHHBF vs RHHBY Comparison Chart in %
Loading...
RHHBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RHHBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RHHBF vs. RHHBY commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RHHBF is a Hold and RHHBY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (RHHBF: $333.36 vs. RHHBY: $40.44)
Brand notoriety: RHHBF and RHHBY are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: RHHBF: 34% vs. RHHBY: 38%
Market capitalization -- RHHBF: $250.69B vs. RHHBY: $250.69B
RHHBF [@Pharmaceuticals: Major] is valued at $250.69B. RHHBY’s [@Pharmaceuticals: Major] market capitalization is $250.69B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RHHBF’s FA Score shows that 2 FA rating(s) are green whileRHHBY’s FA Score has 2 green FA rating(s).

  • RHHBF’s FA Score: 2 green, 3 red.
  • RHHBY’s FA Score: 2 green, 3 red.
According to our system of comparison, RHHBY is a better buy in the long-term than RHHBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RHHBF’s TA Score shows that 2 TA indicator(s) are bullish while RHHBY’s TA Score has 5 bullish TA indicator(s).

  • RHHBF’s TA Score: 2 bullish, 5 bearish.
  • RHHBY’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, RHHBY is a better buy in the short-term than RHHBF.

Price Growth

RHHBF (@Pharmaceuticals: Major) experienced а -4.28% price change this week, while RHHBY (@Pharmaceuticals: Major) price change was -1.80% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.19%. For the same industry, the average monthly price growth was +2.56%, and the average quarterly price growth was +9.33%.

Reported Earning Dates

RHHBY is expected to report earnings on Jul 24, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+1.19% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RHHBF($251B) and RHHBY($251B) have the same market capitalization . RHHBF has higher P/E ratio than RHHBY: RHHBF (21.19) vs RHHBY (19.46). RHHBY YTD gains are higher at: 19.796 vs. RHHBF (10.684). RHHBF (19.1B) and RHHBY (19.1B) have comparable annual earnings (EBITDA) . RHHBF (7.51B) and RHHBY (7.51B) have equal amount of cash in the bank . RHHBF (25.4B) and RHHBY (25.4B) have identical debt. RHHBF (60B) and RHHBY (60B) have equivalent revenues.
RHHBFRHHBYRHHBF / RHHBY
Capitalization251B251B100%
EBITDA19.1B19.1B100%
Gain YTD10.68419.79654%
P/E Ratio21.1919.46109%
Revenue60B60B100%
Total Cash7.51B7.51B100%
Total Debt25.4B25.4B100%
FUNDAMENTALS RATINGS
RHHBF vs RHHBY: Fundamental Ratings
RHHBF
RHHBY
OUTLOOK RATING
1..100
5064
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
15
Undervalued
PROFIT vs RISK RATING
1..100
10079
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
5450
P/E GROWTH RATING
1..100
2017
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RHHBY's Valuation (15) in the null industry is in the same range as RHHBF (16). This means that RHHBY’s stock grew similarly to RHHBF’s over the last 12 months.

RHHBY's Profit vs Risk Rating (79) in the null industry is in the same range as RHHBF (100). This means that RHHBY’s stock grew similarly to RHHBF’s over the last 12 months.

RHHBY's SMR Rating (99) in the null industry is in the same range as RHHBF (99). This means that RHHBY’s stock grew similarly to RHHBF’s over the last 12 months.

RHHBY's Price Growth Rating (50) in the null industry is in the same range as RHHBF (54). This means that RHHBY’s stock grew similarly to RHHBF’s over the last 12 months.

RHHBY's P/E Growth Rating (17) in the null industry is in the same range as RHHBF (20). This means that RHHBY’s stock grew similarly to RHHBF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RHHBFRHHBY
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
70%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
78%
Bearish Trend 4 days ago
43%
Momentum
ODDS (%)
Bearish Trend 4 days ago
64%
Bullish Trend 4 days ago
46%
MACD
ODDS (%)
Bearish Trend 4 days ago
76%
Bearish Trend 4 days ago
48%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
55%
Bearish Trend 4 days ago
49%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
60%
Bearish Trend 4 days ago
52%
Advances
ODDS (%)
N/A
Bullish Trend 25 days ago
51%
Declines
ODDS (%)
Bearish Trend 7 days ago
54%
Bearish Trend 7 days ago
46%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
38%
Aroon
ODDS (%)
Bullish Trend 4 days ago
64%
Bullish Trend 4 days ago
35%
View a ticker or compare two or three
Interact to see
Advertisement
RHHBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RHHBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MRMD0.09N/A
+0.70%
MariMed Inc.
PTIZF1.32N/A
N/A
PT Indo Tambangraya Megah
DHTRF9.81N/A
N/A
DRI HEALTHCARE TR
ZLNDY16.52-0.19
-1.14%
ZALANDO SE
MVMDF0.02N/A
-5.04%
Mountain Valley MD Holdings Inc.

RHHBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, RHHBF has been loosely correlated with RHHBY. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if RHHBF jumps, then RHHBY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RHHBF
1D Price
Change %
RHHBF100%
N/A
RHHBY - RHHBF
36%
Loosely correlated
-1.73%
RHHVF - RHHBF
29%
Poorly correlated
-2.91%
OTSKY - RHHBF
10%
Poorly correlated
-1.50%
PTKFY - RHHBF
6%
Poorly correlated
N/A
SNPHY - RHHBF
6%
Poorly correlated
+1.80%
More

RHHBY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RHHBY has been loosely correlated with RHHVF. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if RHHBY jumps, then RHHVF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RHHBY
1D Price
Change %
RHHBY100%
-1.73%
RHHVF - RHHBY
66%
Loosely correlated
-2.91%
RHHBF - RHHBY
36%
Loosely correlated
N/A
ABBV - RHHBY
21%
Poorly correlated
-0.77%
JNJ - RHHBY
20%
Poorly correlated
+0.29%
CHGCY - RHHBY
20%
Poorly correlated
-0.89%
More